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Abstract Prostaglandins (PG) have been described as media- 
tors in spinal nociceptive processing after peripheral inflamma- 
tion. Enzymes essential for PG biosynthesis, cyclooxygenase 
isozymes COX-1 and COX-2, have not yet been investigated in 
the spinal cord. In two studies on rats with adjuvant-induced 
peripheral inflammation levels of mRNA expression of both 
COX isoforms were analyzed in the lumbar section of the spinal 
curd using reverse transcription-polymerase chain reaction (RT- 
PCR) technique. We could show that mRNA of both COX 
isoforms is expressed constitutively in the spinal cord with COX- 
2 as the predominant isoform. Six hours after induction of 
peripheral inflammation, levels of COX-2 mRNA expression 
were raised significantly in respect o untreated control rats and 
returned to baseline within 3 days after induction of inflamma- 
tion. COX-2 might therefore be regarded as the COX isozyme 
responsible for spinal PG release in nociceptive processing under 
a peripheral inflammatory stimulus. 
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densa of the kidney [8] the testis or the brain, where COX-2 is 
not only expressed constitutively but also considered to be the 
dominating COX isoform [9-11]. In the central nervous sys- 
tem (CNS) prostaglandins maintain important functions as 
neuroregulators [12]. It has been reported that PGs are re- 
leased from the spinal cord by various processes as stimula- 
tion of afferent nerves [13], noxious thermal stimulation [14] 
and by increased potassium levels [15]. Prostaglandins are also 
known to be involved in transmission of nociceptive informa- 
tion in the spinal cord after peripheral inflammation [16]. 
Functional evidence thus indicates a role for cyclooxygenases 
in the spinal cord, expression of the enzyme itself, however, 
has not yet been investigated. We conducted two studies to 
determine the spinal presence and distribution of COX iso- 
zymes using the rat model of adjuvant-induced inflammation. 
Tissue samples of hindpaws and the lumbar section of the 
spinal cord were taken before and after induction of inflam- 
mation and examined for levels of COX mRNA expression by 
reverse transcription-polymerase chain reaction (RT-PCR). 
1. Introduction 2. Materials and methods 
Prostaglandins (PG) have been known as important pro- 
i~flammatory mediators for a long time and cyclooxygenases 
a~ the enzymes responsible for PG formation have been well 
characterized over the last years. Two isoforms of cyclooxy- 
gt.nase have been identified. Beside the well-studied 'classical' 
is,)form of cyclooxygenase, COX-l,  now often referred to as 
the constitutive isoform that is expressed in most tissues and 
thought o mediate physiological responses, a second induci- 
ble isoform of cyclooxygenase, COX-2, is known today [1]. 
COX-2 is barely detectable in cultured cells but its expression 
is highly regulated in response to growth factors or cytokines. 
b~duction of this isozyme could be shown in a variety of cell 
t3 pes by a number of stimuli [2,3]. In vivo experiments re- 
waled expression of COX-2 to be up-regulated by inflamma- 
tory processes [4-7]. In some tissues, however, COX-2 is pres- 
evt without obvious stimulatory processes as in the macula 
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2.1. Animals and tissue preparation 
Experiments were performed on two groups of male Sprague-Daw- 
ley rats (Charles River, Sulzfeld, Germany) weighing 280-320 g and 
160-200 g, respectively. Arthritis was induced by plantar injection of 
complete Freund's type adjuvant (CFA) in one hind footpad [17]. 
Animals were treated with a dosis of 100 ~tl of CFA (Mycobacterium 
sp. suspended in mineral oil at 10 mg/ml; DIFCO Laboratories, De- 
troit, MI) or physiological saline and killed under CO2 at 6 h, 24 h, 
3 days and 7 days after inoculation i  the first study and 3 h, 6 h, 12 
h, 24 h and 72 h in the second study (groups of 3). The study protocol 
was approved by the local Ethics Committee. The spinal cord was 
ejected from the lumbar section of the spine by a water-filled syringe 
and shock-frozen in liquid nitrogen. For the first study the lumbar 
section of the spinal cord was divided laterally into an ipsi- and 
contralateral half and frozen separately. Tissue from both inflamed 
and untreated hindpaws was removed in total without bones. 
2.2. RNA isolation 
Tissue samples from spinal cord and hindpaws of individual ani- 
mals were homogenized and total RNAs isolated by a slightly mod- 
ified protocol of Chomczynski and Sacchi [18]. RNA (40 ktg) was 
treated with 10 U of RNase-free DNase I (Boehringer Mannheim) 
for 1-2 h at 25°C to remove any contaminating DNA. RNA was 
then phenol-extracted, ethanol-precipitated an  stored in aliquots at 
-20°C. RNA integrity and yields were assessed by UV 
spectrophotometry and ethidium bromide staining. To exactly deter- 
mine the amount of RNA taken into the RT-PCR experiments, 2 lag 
aliquots of RNA were run out on 1.2% formaldehyde agarose gels 
(1 × MOPS as running buffer) every time RNA was used in reverse 
transcription experiments and the amount of 18S-rRNA evaluated 
densitometrically after ethidium bromide staining. RNA concentra- 
tions were then corrected for 18S-rRNA values. 
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2.3. Northern blotting 
RNA was separated on 1.2% formaldehyde agarose gels and trans- 
ferred to nylon membrane by capillary blotting using 20×SSC. 
Northern hybridizations and washes were conducted as described pre- 
viously [19]. For detection of hindpaw mRNAs the following specific 
cDNA probes from the coding regions of the genes were used: 
GAPDH probe as described by Stroebel and Goppelt-Struebe [19], 
2.767 kb and 1.156 kb EcoRI fragments from the 5'-end of the 
COX-1 and COX-2 genes, respectively [21]. 
2.4. Reverse transcription-polymerase chain reaction 
DNase-treated RNA (0.05 0.2 p.g) was reverse-transcribed with 
random hexamer or oligo-dT primers (Eurogentec, Belgium) using 
5 mM MgCI2, 1 U of RNase inhibitor (Promega, WI), 4 mM dNTPs, 
50 U of Moloney murine leukemia virus reverse transcriptase (M- 
MLV-RT, Promega) and 1 × buffer supplied by the manufacturer in 
a total volume of 20 BI. A parallel reaction without reverse transcrip- 
tase was run for each sample. The RT reaction was incubated at 37°C 
and 42°C for 20 min each and then stopped by heating to 99°C for 
5 min. Aliquots (5 /.tl) of the reaction were diluted to 25 lal with 1 × 
PCR-buffer (10 mM Tris-HC1, 3.5 mM MgC12, 75 mM KC1, pH 8.3) 
and used for PCR amplification with COX- or GAPDH-specific 
primers (0.15/aM) and 0.2 U of Taq polymerase (Boehringer Mann- 
heim). Samples were placed in a trioblock thermal cycler (Biometra, 
G6ttingen) and initially denatured at 95°C for 2 min. They were then 
denatured at 95°C for 1 min, annealed and extended at 64°C 
(GAPDH primers) or 72°C (COX-1 and COX-2 primers) for 5 min 
in repetitive cycles. Final extension time was 7 min at 72°C. Ten 
microliters of the PCR reaction were resolved by electrophoresis 
through a 2% agarose gel. Amplified cDNA bands were detected by 
ethidium bromide staining and the volumes evaluated by densitometry 
(Vilber-Lourmat, Bio 1D). The yield of the amplified product was 
tested to be linear for amount of input RNA and PCR cycle number. 
For RT-PCR of spinal cord RNA the following optimized conditions 
were chosen: 0.2 Bg of total RNA in 30-34 cycles for assessment of
COX-1 expression and 0.05 ~tg RNA in 28 32 PCR cycles for COX-2 
mRNA expression (data not shown). Experiments were therefore con- 
ducted at 0.2 ktg RNA/32 cycles for COX-1 and 0.05 p.g RNA/30 
cycles for COX-2 mRNA amplification. RNAs from hindpaws were 
investigated at0.2 lag/28 cycles for COX-1 and COX-2 and 0.05 ktg/22 
cycles for GAPDH expression. 
2.5. PCR primers and probes 
PCR primers were selected from the published cDNA sequences 
[6,20] and commercially synthesized (Eurogentec, Belgium). The fol- 
lowing primers were used for the genes of interest: COX-1 5'-forward 
primer CATGGATCCGGATTGGTGGGGGTAG and 3'-reverse 
primer ATCTCGAGGGGCAGGTCTTGGTGTTG, COX-2 5'-for- 
ward CTGTATCCCGCCCTGCTGGTG and 3'-reverse primer 
ACTTGCGTTGATGGTGGCTGTCTT, GAPDH 5'-forward primer 
CCTTCATTGACCTCAACTAC and 3'-reverse primer GGAAGGC- 
Table 1 
Increase in paw volumes of adjuvant- and saline-injected animals 
Time increase in paw volume [%0 over control] 
(h) 
CFA-treated animals saline-treated animals 
ipsilateral contralateral ipsilateral contralateral 
First study 
6 80+ 15 1.2+0.2 nd nd 
24 101 + 17 1.2+0.9 nd nd 
72 95+22 7.3+0.6 12+5 18 +416 
8 162+51 1 +0.2 11_+9 1 _+2 
Second study 
3 73+21 0+1 0 _+1 0 _+ 1 
6 97+14 30+15 3.2+5 2.3+ 1.2 
12 83+12 18_+10 1.1_+2 2.6_+ 2.3 
24 85_+13 3 +4 8.2+6 16 _+10 
72 89_+ 6 8+7 5_+4 20 +17 
Development of inflammation was assessed by increase in paw vo- 
lumes in adjuvant (CFA)- and saline-treated animals (% over con- 
trol). Paw volumes were determined by plethysmographic measure- 
ment of both inflamed (ipsilateral) and uninflamed (contralateral) 
hindpaws (nd, not done). 
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Fig. 1. Expression of COX-2 mRNA in hindpaw tissue. COX-2 
mRNA expression was analyzed in hindfoot tissue after adjuvant- 
induced peripheral inflammation in ipsilateral inflamed paws (a+b) 
and contralateral uninflamed paws (c+d). RNA levels were moni- 
tored over a timecourse of 7 days by Northern blot analysis (a and 
c) and RT-PCR (b and d). GAPDH expression was used as internal 
control for RNA loading. 
CATGCCAGTGAGC. These primer pairs were found to yield am- 
plified products of the expected sizes of 447 bp for the COX-1 cDNA, 
279 bp for COX-2-cDNA and 574 bp for GAPDH. Southern blot 
analysis using specific cDNA-probes for COX-1 and COX-2 (see be- 
low) confirmed the identity of the amplified products. 
2.6. Statistics 
Data were statistically assessed by analysis of variance (ANOVA). 
The significance l vel was set at P < 0.05. 
3. Results 
3.1. Expression of  cyclooxygenase mRNA in inflamed 
peripheral tissue 
Peripheral inf lammation was induced in the rat hindfoot by 
injections of CFA [17]. Development of arthritis was moni- 
tored by increase in paw volume of the animals (Table 1). In 
both studies CFA-inoculated paws were swollen distinctly 6 h 
after induction of the inflammation. Hindfeet had about twice 
the normal size throughout he first 3 days in both experi- 
ments and reached a maximum swelling at the seventh day 
(162% over control). Over a time course of 7 days tissues from 
inflamed hindpaws as well as from contralateral untreated 
paws of individual animals were screened for COX-2 
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I- g. 2. Expression of COX mRNA in the lumbar spinal cord after 
p,xipheral inflammation. Total RNA was isolated from the ipsilater- 
aily located sections of the lumbar spinal cord of animals killed at 
0 h, 6 h and 24 h after induction of peripheral inflammation and 
sLreened for expression of COX-1 and COX-2 mRNA by RT-PCR. 
0 2 p_g RNA/32 cycles were used to detect COX-l, 0.05 ~tg RNA/30 
c cles for COX-2. 18S-rRNA was used as control for RNA load. 
(])ata shown are from 6 animals killed at times indicated.) 
nRNA expression by Northern analysis and RT-PCR. The 
p,'ofile of COX-2 mRNA expression in hindfoot tissue over 
t!te first days of adjuvant-induced inflammation is shown in 
F ig. 1. Tissue from untreated (0 h) or saline-inoculated (con- 
t~ ol) paws did not show distinctable vels of COX-2 mRNA 
e~pression. The level of COX-2 mRNA expression was sig- 
nificantly elevated (P< 0.05) 6 h after inoculation of the ad- 
j~ vant. High levels of COX-2 mRNA were maintained in the 
i~,flamed hindpaws throughout the monitored time course. 
Data from the Northern analysis of COX-2 mRNA expres- 
son (Fig. la,c) were in agreement with data obtained from 
t te RT-PCR (Fig. lb,d). This technique was further applied 
hen analyzing levels of COX mRNA expression in tissue 
s.tmples from the spinal cord, as RNA preparations from 
sl~inal cord tissue of individual animals did not yield sufficient 
a nounts of specific COX mRNA to be detected by Northern 
a lalysis. 
3 2. Investigation of cyclooxygenase isoform expression in the 
spinal cord 
Cyclooxygenase expression in the spinal cord was investi- 
~tted in two separate studies on male Sprague-Dawley rats. 
,Animals were killed at the mentioned timepoints after induc- 
tgn of inflammation and the lumbar sections of the spinal 
c~rds removed as described. Total RNA was isolated and 
It vels of COX-1 and COX-2 mRNA expression analyzed by 
I¢ T-PCR. For validation of RT-PCR see Section 2. 
3 3. Results from the.first study 
The first study was conducted on 21 animals in groups of 
tL tree which were inoculated with CFA or physiological saline 
a ld killed after 6 h, 24 h, 3 days and 7 days, saline controls 
b ring taken after 3 and 7 days only. Untreated animals were 
used as controls for baseline mRNA expression. Lumbar 
s~inal cords were cut longitudinally and both halves were 
a mlyzed separately as sections of the cord correlating to the 
i t,silateral inflamed and the contralateral uninflamed hindfoot. 
Both sections of the spinal cord tissue from untreated control 
r,,.ts showed a basic expression of COX-1 and COX-2 isozyme 
mRNA (Fig. 2). COX-2 was found to be the predominant 
isoform in the spinal cord. A 4-fold amount of RNA and 
additional cycles had to be used for COX-1 mRNA detection. 
167 
Cyclooxygenase mRNA levels were compared in each group 
of animals as well as between groups of different imepoints. 
A marked difference in COX-2 mRNA levels could be de- 
tected at 6 h and 24 h after induction of peripheral inflamma- 
tion in both ipsi- and contralateral sections of the lumbar 
spinal cord, whereas COX-1 mRNA expression seemed to 
be unchanged in this setting. In spinal tissue COX-2 mRNA 
levels were significantly elevated at 6 h in all screens and had 
returned to baseline after 3 days (Fig. 5). 
3.4. Results from the second study 
A second study was performed to analyze the early phase of 
inflammation i more detail. This study included 33 animals 
in groups of three which received plantar injections of adju- 
vant and normal saline, respectively, and were killed at 3 h, 
6 h, 12 h, 24 h and 72 h after injection. Spinal cord tissue was 
not split longitudinally in this case as the first study could not 
reveal significant differences between COX mRNA expression 
in the ipsi- and contralateral halves of the lumbar cord. 
Spinal COX mRNA levels were compared in the first three 
groups of animals, killed at 0 h, 3 h and 6 h after injection of 
CFA (Fig. 3). Densitometric quantitation revealed that levels 
of COX-1 mRNA were comparable in all animals (n = 9). In 
contrast, COX-2 mRNA expression was enhanced over time, 
being significantly increased at 6 h after induction of the per- 
ipheral inflammation. As observed in the first study, COX-2 
mRNA levels returned to baseline within 3 days. These find- 
ings were confirmed in screens comparing animals from all 
i [~o~ 
COX-2 
I I I  I I I 
Oh 3h 6h 
18S-rRNA 
B 
16000 
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Fig. 3. Spinal COX mRNA expression within 6 h of induction of 
inflammation. RNA was isolated from total lumbar spinal cord of 
animals killed at the given timepoints (n--3) and analyzed for COX 
mRNA expression by RT-PCR (a). A significant increase in COX-2 
mRNA levels could be detected at 6 h after induction of peripheral 
inflammation, whereas COX-1 mRNA expression remained un- 
changed in the spinal inflammatory response (b). (Data obtained 
from second study.) *P<0.05. 
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Fig. 4. Levels of lumbar COX-2 mRNA expression. Levels of spinal 
COX-2 expression were compared in adjuvant (CFA)- and saline 
(SAL)-treated animals over a timecourse of 72 h. (Data obtained 
from the second study.) COX-2 mRNA levels were transitionally in- 
creased after 6 h and had returned to baseline at 24 h latest (n = 3 
per timepoint, duplicate values). COX-2 mRNA expression is cor- 
rected for 18S-rRNA levels, expression i untreated animals is set 
to 100% in each screen. *P < 0.05. 
different time points (Fig. 4). Animals injected with saline and 
killed at the same time as adjuvant-treated animals howed no 
significant elevation in the spinal expression of COX-2 mRNA 
over the monitored time course (Fig. 4). Fig. 5 gives a sum- 
mary on COX-2 mRNA levels in the two studies. Comparable 
time courses for COX-2 mRNA expression were found in 
both studies with rapid increases after 6 h and declines to 
baseline after 3 days at latest. 
4. Discussion 
A number of investigations has been conducted in recent 
years to show that prostaglandins are involved in nociceptive 
processing in the CNS [22]. A functional role for prostagland- 
ins in the spinal cord has been confirmed by intrathecal ad- 
ministration of COX products such as PGE2, PGD~ and 
PGF2a [23,24]. Evidence has also been presented for spinal 
actions of NSAIDs, which are known to inhibit COX function 
[25]. In vivo studies showed direct influence of intrathecally 
administered NSAIDs [16,26,27] on spinal nociceptive 
processing, hereby diminishing nociceptive behaviour. Maim- 
berg and Yaksh [28] could also demonstrate hat NSAIDs are 
100-500 times as active when administered spinally in com- 
parison to systemic administration. In this context, several 
studies have investigated the role of prostaglandins in the 
spinal modulation of thermal and mechanical hyperalgesia 
[27-29]. Although opinions on whether PGs are involved in 
both these hyperalgesic processes are still contradictory, it has 
already become vident hat there is a definite role for PGs in 
the modulation of the nociceptive responses from the periph- 
ery. 
It has been discussed for some time that the analgesic action 
of NSAIDs should be dissociated from their anti-inflamma- 
tory actions [16,30,31]. PG synthesis nhibition in the inflamed 
tissue is obviously related to the anti-inflammatory effect of 
NSAIDs, whereas the analgesic action seems to be related to 
the antinociceptive effect on a possible spinal site of action 
[30,32,33]. 
The cerebral presence of the prostanoid-forming cyclooxy- 
genases has been documented in several studies [9-11]. In our 
studies presented here we could now show direct evidence for 
the presence of both COX isoforms in the rat spinal cord. 
COX-2 was found to be the predominantly expressed isoform 
in the lumbar section of the cord. Predominance of COX 
isozyme expression thus seems to be similar as described for 
sections of the brain [9]. 
In this model of peripheral inflammation the functional role 
of spinal cyclooxygenases was investigated. Injection of 
Freund's adjuvant led to paw swelling accompanied by a 
rise in COX-2 mRNA expression in the inflamed paw 6 h 
after induction of inflammation. At that timepoint we could 
also detect a rise in the level of COX-2 mRNA expression i  
the lumbar section of the spinal cord, while COX-1 mRNA 
expression remained steady at baseline. In both studies a max- 
imum increase in COX-2 mRNA was observed after 6 h. The 
decline was slightly slower in the first study but also reached 
background levels after 3 days. This timecourse covers most 
of the acute phase of inflammation. Whether the slow rise in 
spinal COX-2 mRNA levels after 7 days of peripheral inflam- 
mation leads to a second induction of expression towards the 
chronical phase of inflammation needs further investigation. 
In contrast o the transient rise in the spinal cord, COX-2 
expression remained elevated at the peripheral site of inflam- 
mation from 6 h after induction of inflammation over the 
whole timecourse of 7 days, correlating with increased vol- 
umes of the inflamed hindfeet. 
A 6 h lag phase for induction of spinal mRNAs was ob- 
served by Ji et al. [34] in the same model of adjuvant-induced 
arthritis. They could demonstrate a rapid increase in neuro- 
peptide Y and neuropeptide Y receptor mRNA expression i  
the ipsilateral dorsal horn neurons 6 h after inoculation of 
unilateral inflammation. In a lateral separation of the lumbar 
spinal cord in sections relating to the inflamed or uninflamed 
hindfoot we could not distinguish significant differences in 
COX-2 mRNA expression between the ipsi- and contralateral 
sections. 
With the methods used in our studies it was not yet possible 
to locate the exact site of COX expression and action. It will 
be interesting to investigate the distribution of cyclooxy- 
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Fig. 5. Comparison of the studies presented. COX-2 mRNA levels 
are significantly elevated in animals killed 6 h after the peripheral 
inflammatory stimulus in both studies. This transient elevation has 
returned to baseline after 3 days in the first and 24 h in the second 
study. At 7 days another small increase in COX-2 mRNA is detect- 
able. *P < 0.05. 
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gcnases in the spinal cord to be able to determine the sites of 
spinal PG synthesis and actions. In the mapping of COX-2- 
like immunostaining in the brain, for instance, high levels of 
er~pression have been found in dendrites and neuronal cell 
b~)dies, i.e. typical postsynaptic structures [9]. Exact mapping 
o" the isozymes will give further insight into the functional 
r,,le of cyclooxygenases in mediating nociception. 
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